Knee Surg Relat Res 2013 Dec; 25(4): 155-164  https://doi.org/10.5792/ksrr.2013.25.4.155
Periprosthetic Knee Infection: Ten Strategies That Work
Javad Parvizi, MD*, Priscilla Ku Cavanaugh, MS, and Claudio Diaz-Ledezma, MD

Department of Orthopaedic Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.

Correspondence to: Correspondence to: Javad Parvizi, MD. Department of Orthopaedic Surgery, Thomas Jefferson University Hospital, 111 S 11th St, Philadelphia, PA 19107, USA. Tel: +1-267-339-7813, Fax: +1-215-503-5651, parvj@aol.com
Received: September 11, 2013; Revised: November 6, 2013; Accepted: November 7, 2013; Published online: November 29, 2013.
© Korean Knee Society. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract

Periprosthetic joint infection (PJI) is one of the most serious complications following total knee arthroplasty (TKA). The demand for TKA is rapidly increasing, resulting in a subsequent increase in infections involving knee prosthesis. Despite the existence of common management practices, the best approach for several aspects in the management of periprosthetic knee infection remains controversial. This review examines the current understanding in the management of the following aspects of PJI: preoperative risk stratification, preoperative antibiotics, preoperative skin preparation, outpatient diagnosis, assessing for infection in revision cases, improving culture utility, irrigation and debridement, one and two-stage revision, and patient prognostic information. Moreover, ten strategies for the management of periprosthetic knee infection based on available literature, and experience of the authors were reviewed.

Keywords: Knee, Arthroplasty, Periprosthetic joint infection, Infection control, Reoperation
Introduction

It is well recognized that a periprosthetic joint infection (PJI) after knee arthroplasty is a catastrophic complication not only for the patient, but also for the health-care system. During the last decade, clinical research has considerably improved our comprehension of this topic. However, we are still in the process of producing high-level evidence to support our daily clinical practice. In this article we will review ten strategies that work in managing knee PJI.

1. Preoperative Risk Stratification

From our standpoint, the first step to succeed in the battle against knee PJI is prevention. Consequently, in order to stratify the patient's risk, knowledge of risk factors in the development of PJI should be mandatory for each surgeon that is involved in knee arthroplasty. Optimization of modifiable variables that may influence this risk is also critical. A recent study by Namba et al.1) evaluated 56,216 total knee arthroplasty (TKA) surgeries. The study found an incidence of deep infection of 0.72% (404/56,216). The risk factors for infection were body mass index (BMI) of ≥35 (hazard ratio [HR], 1.47), diabetes mellitus (HR, 1.28), male sex (HR, 1.89), an American Society of Anesthesiologists (ASA) score of ≥3 (HR, 1.65), osteonecrosis (HR, 3.65), and posttraumatic arthritis (HR, 3.23). Hispanic race was a protective factor (HR, 0.69), the use of antibiotic irrigation (HR, 0.67), a bilateral procedure (HR, 0.51), and a lower annual hospital volume (HR, 0.33). Surgical risk factors included quadriceps-release exposure (HR, 4.76), and the use of antibiotic-laden cement (HR, 1.53). Operative time was a risk factor, with a 9% increased risk per fifteen-minute increments. Although some risk factors found in this study are debatable, the study highlights some of the important predisposing factors for infection.

Obesity and diabetes are both well-known risk factors for knee PJI. According to the American Association of Hip and Knee Surgeons (AAHKS), prior to surgery, a patient with a BMI over 40 should be counseled regarding weight loss2). In addition, AAHKS has emphasized the importance of a nutritional evaluation prior to surgery2). Regarding diabetes, a large Finnish study corroborated its relevance as a strong risk factor for infections3). Although Hemoglobin A1C has been used to evaluate arthroplasty patients, a recent publication from Iorio et al.4) showed that it is probably a suboptimal preoperative measurement due to its inability to prognosticate complications. We believe that an exhaustive preoperative evaluation, and glycemic level optimization is an indispensable component of the preoperative work up, and must be conducted by a general internist, or medicine subspecialist. Currently, the evidence is not able to present a definite threshold regarding BMI and glycemic control in order to establish a clear preoperative recommendation for knee arthroplasty patients.

Another attractive strategy is to calculate a preoperative risk of PJI using a scoring system. The Mayo Clinic recently presented a prosthetic joint infection risk score, which demonstrated a good capacity to discriminate subjects who will develop a PJI from those who will not (C-index of 0.722)5). It includes the BMI, presence of prior operations on the index joint, prior arthroplasty, immunosuppression, ASA score, and procedure duration5). After adding postoperative wound drainage to the previous variables, the 1-month post surgery risk score presents a C- index of 0.716.

A recent study conducted in Korea described a prevalence of surgical site infections (SSI) in 161 of 6,848 cases (2.35%)6). Interestingly, the authors suggested that the risk factors for SSI differ between total hip arthroplasty (THA), and TKA. Independent risk factors for SSI in TKA were male gender, and an operating room without laminar flow. More than 10 procedures per month was a protective factor for knee PJI6).

A recent systematic review and meta-analysis indicate that, compared with osteoarthritis (OA) patients, patients with rheumatoid arthritis have a higher risk of infection following TKA7).

Another important risk factor is revision surgical procedures8). A study from our institution revealed that the risk of infection among patients undergoing revisions was 10-fold higher (9%)8) than for patients undergoing primary TKA (0.5%-1%)9). The risk was predicted by factors such as revision due to infection, higher Charlson comorbidity index, and diagnosis other than OA at the time of the primary procedure.

Understanding the risk factors for PJI, allows implementation of strategies that aims to reverse some of these potential risk factors and reduce the burden of infection.

2. Preoperative Antibiotics

One of the most effective strategies for the prevention of infection in modern orthopaedic literature is the administration of preoperative antibiotics10,11). In order to achieve optimal results, adequate concentration of antibiotics should be present during the entire time the incision is open, when the greatest risk for contamination is present10). For predictable and rapid delivery of antibiotics, systematic intravenous (IV) administration is the method of choice12).

Conflicting opinions exist as to what the optimal time window for prophylaxis administration should be12). Some studies have shown that the best time for administration is within 30 minutes of incision13), while others support administration within 30-59 minutes14). Based on The American Academy of Orthopaedic Surgeons (AAOS) and The Centers for Disease Control (CDC) guidelines, prophylactic antibiotics should be administered within one hour before the surgical incision15). When a proximal tourniquet is used, administration of the entire dose of antibiotic should occur before inflation of the tourniquet12,15). Duration of antibiotic coverage should not exceed 24 hours postoperatively15), doing so may increase the risk for adverse effects of antibiotics without proven benefits15,16). Avoiding unnecessary antibiotic use will also minimize the risk ofbacterial resistance17). Furthermore, intraoperative dose of antibiotic should be repeated if there is significant blood loss, or if operative time exceeds two times the half-life of antibiotic15,18).

Currently, the most widely used prophylactic antibiotics for prevention of PJI are first and second generation cephalosporins because of their excellent tissue penetration, bioavailability, and coverage against common organisms such as Staphylococcus species, and enteric pathogens12). In patients undergoing orthopaedic procedures, cefuroxamine and cefazolin are the preferred antibiotics14). These antibiotics may not be appropriate in certain cases, and the addition of vancomycin may be warranted12,15). AAOS guidelines recommend vancomycin in facilities with methicillin-resistant staphylococcus aureus (MRSA) outbreaks, and in patients with known MRSA colonization15). Additionally, vancomycin should be considered in institutionalized patients (dialysis-dependent patients and nursing home residents), and health care workers12). Patients with a documented anaphylactic reaction to penicillin can either receive clindamycin or vancomycin12,15), however, our institution prefers vancomycin to avoid the potential for clindamycin-associated clostridium difficile enteritis12).

3. Skin Preparation

Preoperative skin preparation is of common practice in the orthopaedic community. Skin preparation prior to surgery includes skin decolonization, antisepsis, hand washing by the surgeon, and hair removal. Ample evidence exists in support of the role of preoperative cleansing in reduction of skin bacteria load19,20), but how this translates to prevention of SSI is unclear.

Preoperative showering or cleansing with an antiseptic agent at least the night before a surgical procedure has been recommended by the CDC21). In two prospective consecutive series, patients who used chlorhexidine gluconate (CHG) impregnated wipes the night before, and the morning of the surgery had a lower incidence of SSI as compared with those who did not comply to the protocol in both THA and TKA procedures. In contrast, a Cochrane review of 7 randomized trials concluded that preoperative showering with CHG did not reduce the rate of SSI as compared to a no shower group or placebo group22). Despite conflicting data regarding preoperative showers reducing SSI incidence, the simplicity and cost-effectiveness of this method justifies its current recommendation23).

Regarding skin preoperative disinfection, the discussion has focused on the selection of an optimal antiseptic agent12). The main types of antiseptic agents are: alcohol based solutions, povidone-iodine and CHG24,25). In studies comparing CHG and povidone-iodine the results are conflicting. Darouiche et al.26) demonstrated that CHG in alcohol was superior in reducing the rate of SSI as compared to aqueous povidone-iodine. However, the iodine preparation in the study did not use an alcohol solvent, hence allowing for the possibility that alcohol may play a role. In fact, in a study involving general surgery patients, povidone-iodine prepped patients had a lower rate of SSI when alcohol was used (either as a solvent or scrub)27). Overall, the literature suggests some value in the combination of alcohol with antiseptic agents, and that CHG combined with alcohol may be superior to other combinations26,28,29).

In regards to preoperative hair removal, the CDC recommends that it should be done immediately before the procedure, and electric clippers are preferred over razor blades12,21). Tanner et al.30) conducted a meta-analysis that showed that electric clippers were associated with fewer SSIs than with razor shaving.

Hand washing by the surgeon and medical personnel is a difficult topic to evaluate due to the variability in the literature regarding duration, and optimal antiseptic agent. One study examining surgical scrub time, and subsequent bacterial growth found no significant difference between a 2 or a 3 minute scrub31). Currently, The Association of Perioperative Registered Nurses states that a 3-4 minute scrub is as effective as a 5 minute scrub, while the CDC recommends 2-5 minutes21). Data on hand rub (alcohol based) and hand scrub agents suggest no significant difference in efficacy between the two32). A trial of 4,387 patients who underwent clean, and clean contaminated surgery using either traditional hand scrubbing techniques or waterless, alcohol-based antiseptics showed no difference in SSI rates33). Based on current literature, medical personnel should consider a minimum duration of 2-3 minutes for surgical hand antisepsis using either hand rub or hand scrub solution31-33).

4. Diagnosis of Periprosthetic Joint Infection

The diagnosis of PJI should be suspected in all patients evaluated for a painful TKA. The AAOS established diagnostic guidelines that help identify PJI of the knee34). The measurement of serum markers such as C-reactive protein (CRP), and the erythrocyte sedimentation rate (ESR) is highly valuable in reaching a diagnosis of PJI. It must be noted that these tests are not diagnostic independently. According to the AAOS34) and the Infectious Diseases Society of America guidelines35), if serum markers are elevated, a joint aspiration should be performed. Our institution always includes cytochemical fluid analysis, and two cultures after every knee aspiration. More recently, we have added the evaluation of the leukocyte esterase test also36).

We encourage the surgeons to be cognizant of the Musculoskeletal Infection Society (MSIS) PJI diagnostic criteria, that aim to provide a standard definition of PJI37). The criteria can be used as a guide to establish a diagnosis when PJI is suspected. Taking into consideration the benefits, costs and risks of different strategies of PJI diagnosis, the use of serum markers followed by knee arthrocentesis is a highly efficient strategy.

A recent study from our group determined the thresholds for serum markers to diagnose PJI using the MSIS criteria. In early postoperative knee PJI, the ESR threshold was 54 mm/hour, and CRP was 23.5 mg/L. In late-chronic knee PJI the thresholds were 46.5 mm/hour for ESR, and 23.5 mg/L for CRP38). A study from another group established that the rate of false negatives was 9.2% for ESR, 5.3% for CRP, and 11% for combined ESR and CRP when diagnosing knee PJI. The authors believe that one of the factors that may explain these observations is that some patients may not mount a sufficient immune response, especially in early postoperative infections39). For this reason, a joint aspiration should be conducted even if serum markers are normal in those cases with high clinical suspicion, or known risk factors for knee PJI.

Our group also presented the value of studying the CRP in the synovial fluid, which may be an additional tool to improve our diagnostic alternatives40).

5. Intraoperative Assessment in Every Revision Case

From our standpoint and according to the recommendations made by the AAOS, surgeons should always perform a PJI diagnostic workup in every revision case. This process should start when the decision to undergo a revision is made, and the strategies described above are used. Once the patient is in the operation room, three main strategies can be employed: 1) cultures, 2) frozen sections, and 3) implant-related studies.

Concerning intraoperative cultures, one of the most important steps is to not withhold the preoperative antibiotics in revision cases. A multicenter randomized study, demonstrated that intraoperative cultures yielded the same organisms as preoperative cultures in 28 of 34 patients (82%) randomized to receive antibiotics before the skin incision compared to 25 of 31 patients (81%) randomized to receive antibiotics after obtaining operative cultures41). In regards to the type of cultures that should be obtained during the surgery, a study conducted in our institution demonstrated that tissue cultures are better than swab cultures. Tissue cultures demonstrated higher sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for diagnosing PJI than swab cultures. Swab cultures had more false-negative and false-positive results than tissue cultures42) Another important strategy is to obtain the synovial fluid culture in blood culture flasks, due to its higher sensitivity, specificity, and both PPV and NPV for diagnosis of PJI when compared with standard tissue and swab samples43).

Regarding the use of frozen sections, it must be noted that they represent one of the diagnostic criteria in the MSIS definition. A recent systematic review and meta-analysis by Tsaras et al.44) showed that intraoperative frozen sections are helpful in the diagnosis of culture-positive PJI, but had moderate accuracy in ruling out this diagnosis. According to the authors, frozen section is especially valuable if the suspicion of infection remains high even after a negative preoperative evaluation. The optimum diagnostic threshold (number of polymorphonuclear leukocyte per high-power field) could not be discerned in this study.

Implant sonication is proving to be an interesting technology45). Its role has not been completely determined in the diagnostic work-up of PJI, especially considering the costs associated.

6. How to Improve the Utility of Cultures?

Cultures of tissue and synovial fluid obtained from an affected joint play a major role in both the diagnosis and treatment of PJI12). These cultures are used to confirm, and not to screen for PJI12). Currently, diagnosis of PJI can be made from two separate fluid or tissue samples from an affected joint37). Not only do cultures confirm a PJI diagnosis, they also allow for sensitivity-guided treatment. However, in 7% to 12% of PJI cases cultures may be negative even when clear signs of infection are present46,47).

Negative cultures may be caused by a variety of reasons, including inappropriate collection of sample, use of antimicrobial therapy prior to collection, short incubation duration, and possible fungal or mycobacterial infection12). In the setting of a true PJI, negative cultures limit the ability to tailor antibiotic treatment and may hinder justification for revision surgery12). Thus, attention should be directed at decreasing the incidence of negative cultures.

Strategy for obtaining positive cultures includes withholding aspiration of joints for at least two weeks prior to sample collection, followed by a prolonged period of incubation12,46). A study by Schaefer et al.48) described that prolonged incubation for at least 14 days increased the identification of organisms that would otherwise remain culture negative. Certain pathogens that are difficult to isolate using traditional cultures include fungi, mycobacteria, and organisms encapsulated in biofilm46). Proper media should be used in cases where fungi or mycobacteria are suspected12). A repeat aspiration should be considered in the event of inconclusive preoperative aspiration, negative cultures, elevated inflammatory markers, and high PJI suspicion12).

7. Irrigation and Debridement: When and How?

The use of irrigation and debridement (I&D) with or without modular exchange as an appropriate alternative for treatment of PJI remains controversial. This less invasive procedure is commonly used despite its rate of success ranging between 0% and 89%49). I&D provides the option for a less complex surgery, and lower cost when compared to two-staged procedures50). The potential advantages of I&D over two-stage exchange justify its continued practice and further investigation of factors that predict its optimal use.

I&D has been considered a viable option for early postoperative or late hematogenous infections51). Previous studies have suggested that the ability of I&D to control infection may be related to its timing relative to index total joint arthroplasty, and duration of symptoms52-54). Hartman et al.52) found significant improvement in I&D success rates if used within 4 weeks of index knee surgery. In addition to short duration of symptoms, the literature suggests a higher I&D success rate in healthier patients, and in infections with low virulent organisms55-58). Azzam et al.59) described that patients with a higher ASA score, had higher failure rates. Furthermore, several studies recognize Staphylococcal infections as a risk factor for failure in I&D60). Thus, I&D should be considered in immunologically optimized patients with acute onset of symptoms infected with low virulent organisms.

Once the decision to perform an I&D procedure is made, preoperative optimization of the patient should be attempted before proceeding12). In the operating room, aggressive debridement of all foreign and affected periarticular tissue should be performed12). At our institution, retained components are scrubbed with Dakin's solution and using a new, clean instrument for each collection, at least 3 tissue samples are then obtained12). Thorough irrigation using low pressure pulse lavage or bulb irrigation of the joint with up to 9 liters of solution is performed12,61,62). Finally, gloves, gowns and surgical setup should be changed between the I&D procedure, and the modular component exchange12).

8. Revision in One Stage: When and How?

One-stage exchange arthroplasty for PJI has become the subject of interest due to potential advantages over two-stage exchange. Main advantages that proponents focus on are the need for a single operation, decreased morbidity, lower cost, and improved functional results63-65). Regarding efficacy of the procedure, several retrospective studies have reported rates of infection control between 73% and 93%66-69).

Although advantages may exist in one-stage exchange, studies emphasize that success of the procedure depends on both patient, and infection related factors12). Jackson and Schmalzried70) performed a literature review to determine when single-stage exchange is most successful in the setting of an infected hip. Variables associated with successful outcomes included the absence of wound complications after index THA, healthy patients, presence of methicillin-sensitive organisms, and organism susceptibility to antibiotic-laden bone cement70). Factors that predicted failure included polymicrobial infection, presence of gram negative organisms, and methicillin-resistant organisms70). Furthermore, the following may be considered contraindications: systemic infection, severe soft tissue involvement, inability to identify a microorganism preoperatively, and presence of a sinus tract10,12,35,70-72). Identifying ways to optimize results of one-stage exchange helps determine appropriate indications. At our institution, indications for one-stage exchange include: a healthy host, acute postoperative infection, susceptible organism, and adequate soft tissue coverage12).

In one-stage exchange arthroplasty, a patient undergoes a radical synovectomy, debridement of infected tissue and removal of foreign material (including prosthesis and cement)65). Multiple cultures should be taken for final culture analysis12). Prior to the reimplantation of the prosthesis, the patient should be re-prepped, and a change of gloves and surgical instruments should occur65). After implantation of the antibiotic impregnated cement, the wound is irrigated with dilute betadine solution before final closure65). Systemic antibiotics are usually given for a total of 6 weeks, beginning with 2 weeks of IV antibiotics followed by 4 weeks of oral antibiotics65).

9. Revision in Two Stages: When and How?

The two-stage exchange arthroplasty is currently the most accepted procedure for the treatment of PJI in North America73-75). Two-stage exchange involves resection of the implants, meticulous debridement and irrigation, placement of a temporary antibiotic-impregnated cement spacer, and delayed component reimplantation12,65). Although the main role of two-stage revision has been in chronic PJI management, it is increasingly considered in cases of acute PJI where initial I&D or one-stage exchange procedures have failed12,76). Literature on two-stage exchange reports variable success rates, and sufficient data directly comparing it to one-stage revision is lacking. However, a recent systematic review demonstrated an average success rate of 90% after two-stage exchange for knee prosthesis infection75). The study also reported that two-stage exchange provided better outcomes than one-stage revision for septic knee prosthesis75).

Currently, there is insufficient data to provide clear indications for two-stage exchange35,70,72). Infections with resistant organisms have been associated with higher failure rates in the treatment of PJI77,78). Some studies suggest that two-stage exchange may be the preferred treatment for highly virulent organisms79,80). Parvizi et al.79) examined surgical treatment success of knee and hip MRSA infections, and reported infection control by I&D and two-stage exchange as 37% and 75% respectively, suggesting superior outcomes with the latter. Furthermore, Oussedik et al.64) reported significant bone loss, and soft-tissue compromise as factors in favor of a two-stage exchange over a one-stage revision. Insufficient soft-tissue coverage may be an indication for two-stage exchange, especially if time is required for flap development. Currently at our institution, common indications for this procedure are as follows: chronic PJI, failed I&D, and acute infections associated with an immunocompromised host or virulent organism12).

Two-stage exchange begins with thorough removal of infected tissue and foreign material, followed by irrigation12). The first stage involves insertion of either a static or dynamic antibiotic-impregnated spacer12), most commonly using vancomycin, tobramycin, and gentamicin as the antibiotic12,81). Postoperatively, the patient receives a course of antibiotic treatment, usually for 6 weeks82), followed by reimplantation of a new prosthesis when the clinician deems the infection resolved12,83-85). A combination of clinical judgment, aspiration, and serological data can aid the clinician's decision on appropriate time for reimplantation12,82).

10. Patient Information about Their Prognosis

A patient diagnosed with a knee PJI should be informed about the prognosis. Providing information is key in maintaining realistic expectations, and avoiding medicolegal issues. Ideally, the patient's family should also be involved during the presentation of prognostic information.

Although the term "successful treatment" in PJI has been widely used, until recently, its definition was non-uniform. Our group found more than 10 different definitions of success in the current literature86), thus, we decided to create a Delphi-based consensus definition. The study was published recently86), and it described success as 1) infection eradication (characterized by a healed wound without fistula, drainage, or pain), and no infection recurrence caused by the same organism strain, 2) no subsequent surgical intervention for infection after reimplantation surgery; and, 3) no occurrence of PJI-related mortality (by causes such as sepsis, necrotizing fasciitis). We expect that in the near future this definition will help us better present prognostic information, and the overall probability to succeed to optimize patient understanding.

In terms of infection eradication, according to a meta-analysis by Jamsen et al.87), the failure to eradicate infection after treatment of a periprosthetic knee infection ranged from 0%-31%. Recurrent infections occurred in 0%-18%, and new infections varied from 0%-31%87). Regarding functional outcomes, Barrack et al.88), in a multicenter study of surgical outcomes following revision knee arthroplasty, patients demonstrated a lower Knee Society Score (KSS) in their cohort of septic revisions compared with revisions for aseptic failure. Concerning the radical management of failed TKA infection treatment, Chen et al.89) demonstrated that patients with knee fusions had better functional scores than knee amputations.

In TKA revisions, Barrack et al.88) demonstrated that revisions due to infection had no differences regarding patients' satisfaction compared with aseptic revision cases. This fact has been supported in a subsequent study by Patil et al.90).

Conclusions

Knee PJI is a devastating complication that is faced by every knee arthroplasty surgeon. We suggest that PJI should be combated in an organized way, establishing institutional or even national protocols in order to decrease the variability in its prevention and management. Based on current knowledge, we highly recommend the inclusion of these ten strategies as preoperative, intraoperative, and postoperative measures to minimize the risk and consequences of periprosthetic knee infection.

References
  1. Namba, RS, Inacio, MC, Paxton, EW. Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees. J Bone Joint Surg Am, 2013;95;775-782.
    Pubmed
  2. Workgroup of the American Association of Hip and Knee Surgeons Evidence Based Committee. Obesity and total joint arthroplasty: a literature based review. J Arthroplasty, 2013;28;714-721.
    Pubmed
  3. Jamsen, E, Nevalainen, P, Eskelinen, A, Huotari, K, Kalliovalkama, J, Moilanen, T. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am, 2012;94;e101.
    Pubmed
  4. Iorio, R, Williams, KM, Marcantonio, AJ, Specht, LM, Tilzey, JF, Healy, WL. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty, 2012;27;726-729.
    Pubmed
  5. Berbari, EF, Osmon, DR, Lahr, B, Eckel-Passow, JE, Tsaras, G, Hanssen, AD, Mabry, T, Steckelberg, J, Thompson, R. The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol, 2012;33;774-781.
    Pubmed
  6. Song, KH, Kim, ES, Kim, YK, Jin, HY, Jeong, SY, Kwak, YG, Cho, YK, Sung, J, Lee, YS, Oh, HB, Kim, TK, Koo, KH, Kim, EC, Kim, JM, Choi, TY, Kim, HY, Choi, HJ, Kim, HB. Differences in the risk factors for surgical site infection between total hip arthroplasty and total knee arthroplasty in the Korean Nosocomial Infections Surveillance System (KONIS). Infect Control Hosp Epidemiol, 2012;33;1086-1093.
    Pubmed
  7. Ravi, B, Escott, B, Shah, PS, Jenkinson, R, Chahal, J, Bogoch, E, Kreder, H, Hawker, G. A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis Rheum, 2012;64;3839-3849.
    Pubmed
  8. Mortazavi, SM, Schwartzenberger, J, Austin, MS, Purtill, JJ, Parvizi, J. Revision total knee arthroplasty infection: incidence and predictors. Clin Orthop Relat Res, 2010;468;2052-2059.
    Pubmed
  9. Pulido, L, Ghanem, E, Joshi, A, Purtill, JJ, Parvizi, J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res, 2008;466;1710-1715.
    Pubmed
  10. Bratzler, DW, Houck, PM, Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg, 2005;189;395-404.
    Pubmed
  11. Prokuski, L. Prophylactic antibiotics in orthopaedic surgery. J Am Acad Orthop Surg, 2008;16;283-293.
    Pubmed
  12. Parvizi J, Kerr GJ, Glynn A, Higuera CA, Hansen EN. Periprosthetic joint infection: practical management guide. New Delhi: Jaypee Brothers Medical Publishers; 2013. p. 121.
  13. van Kasteren, ME, Mannien, J, Ott, A, Kullberg, BJ, de Boer, AS, Gyssens, IC. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin Infect Dis, 2007;44;921-927.
    Pubmed
  14. Weber, WP, Marti, WR, Zwahlen, M, Misteli, H, Rosenthal, R, Reck, S, Fueglistaler, P, Bolli, M, Trampuz, A, Oertli, D, Widmer, AF. The timing of surgical antimicrobial prophylaxis. Ann Surg, 2008;247;918-926.
    Pubmed
  15. American Academy of Orthopaedic Surgeons. Recommendations for the Use of Intravenous Antibiotic Prophylaxis Information Statement [Internet]. IL: American Academy of Orthopaedic Surgeons; [cited 2013 Aug 10]. , Available from: http://www.aaos.org/about/papers/advistmt/1027.asp
  16. McDonald, M, Grabsch, E, Marshall, C, Forbes, A. Single-versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg, 1998;68;388-396.
    Pubmed
  17. Harbarth, S, Samore, MH, Lichtenberg, D, Carmeli, Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation, 2000;101;2916-2921.
    Pubmed
  18. Page, CP, Bohnen, JM, Fletcher, JR, McManus, AT, Solomkin, JS, Wittmann, DH. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg, 1993;128;79-88.
    Pubmed
  19. Kalmeijer, MD, Coertjens, H, van Nieuwland-Bollen, PM, Bogaers-Hofman, D, de Baere, GA, Stuurman, A, van Belkum, A, Kluytmans, JA. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis, 2002;35;353-358.
    Pubmed
  20. Perl, TM, Cullen, JJ, Wenzel, RP, Zimmerman, MB, Pfaller, MA, Sheppard, D, Twombley, J, French, PP, Herwaldt, LA, Mupirocin And The Risk Of Staphylococcus Aureus Study Team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med, 2002;346;1871-1877.
    Pubmed
  21. Mangram, AJ, Horan, TC, Pearson, ML, Silver, LC, Jarvis, WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control, 1999;27;97-132.
    Pubmed
  22. Webster, J, Osborne, S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev, 2007;;CD004985.
    Pubmed
  23. Zywiel, MG, Daley, JA, Delanois, RE, Naziri, Q, Johnson, AJ, Mont, MA. Advance pre-operative chlorhexidine reduces the incidence of surgical site infections in knee arthroplasty. Int Orthop, 2011;35;1001-1006.
    Pubmed
  24. O'Grady, NP, Alexander, M, Dellinger, EP, Gerberding, JL, Heard, SO, Maki, DG, Masur, H, McCormick, RD, Mermel, LA, Pearson, ML, Raad, II, Randolph, A, Weinstein, RA. Guidelines for the prevention of intravascular catheter-related infections: the Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics, 2002;110;e51.
    Pubmed
  25. Olson, LK, Morse, DJ, Duley, C, Savell, BK. Prospective, randomized in vivo comparison of a dual-active waterless antiseptic versus two alcohol-only waterless antiseptics for surgical hand antisepsis. Am J Infect Control, 2012;40;155-159.
    Pubmed
  26. Darouiche, RO, Wall, MJ, Itani, KM, Otterson, MF, Webb, AL, Carrick, MM, Miller, HJ, Awad, SS, Crosby, CT, Mosier, MC, Alsharif, A, Berger, DH. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med, 2010;362;18-26.
    Pubmed
  27. Swenson, BR, Hedrick, TL, Metzger, R, Bonatti, H, Pruett, TL, Sawyer, RG. Effects of preoperative skin preparation on postoperative wound infection rates: a prospective study of 3 skin preparation protocols. Infect Control Hosp Epidemiol, 2009;30;964-971.
    Pubmed
  28. Keblish, DJ, Zurakowski, D, Wilson, MG, Chiodo, CP. Preoperative skin preparation of the foot and ankle: bristles and alcohol are better. J Bone Joint Surg Am, 2005;87;986-992.
    Pubmed
  29. Ostrander, RV, Botte, MJ, Brage, ME. Efficacy of surgical preparation solutions in foot and ankle surgery. J Bone Joint Surg Am, 2005;87;980-985.
    Pubmed
  30. Tanner, J, Norrie, P, Melen, K. Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst Rev, 2011;;CD004122.
    Pubmed
  31. Wheelock, SM, Lookinland, S. Effect of surgical hand scrub time on subsequent bacterial growth. AORN J, 1997;65;1087-1092.
    Pubmed
  32. Tanner, J, Swarbrook, S, Stuart, J. Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst Rev, 2008;;CD004288.
    Pubmed
  33. Parienti, JJ, Thibon, P, Heller, R, Le Roux, Y, von Theobald, P, Bensadoun, H, Bouvet, A, Lemarchand, F, Le Coutour, X, Antisepsie Chirurgicale des mains Study Group. Hand-rubbing with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and 30-day surgical site infection rates: a randomized equivalence study. JAMA, 2002;288;722-727.
    Pubmed
  34. Adopted by the American Academy of Orthopaedic Surgeons Board of Directors. The diagnosis of periprosthetic joint infections of the hip and knee: guideline and evidence report [Internet]. IL: American Academy of Orthopaedic Surgeons; [cited 2012 Feb 2]. , Available from: http://www.aaos.org/research/guidelines/PJIguideline.pdf
  35. Osmon, DR, Berbari, EF, Berendt, AR, Lew, D, Zimmerli, W, Steckelberg, JM, Rao, N, Hanssen, A, Wilson, WR, Infectious Diseases Society of America. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis, 2013;56;1-10.
    Pubmed
  36. Aggarwal, VK, Tischler, E, Ghanem, E, Parvizi, J. Leukocyte esterase from synovial fluid aspirate: a technical note. J Arthroplasty, 2013;28;193-195.
    Pubmed
  37. Parvizi, J, Zmistowski, B, Berbari, EF, Bauer, TW, Springer, BD, Della Valle, CJ, Garvin, KL, Mont, MA, Wongworawat, MD, Zalavras, CG. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res, 2011;469;2992-2994.
    Pubmed
  38. Alijanipour, P, Bakhshi, H, Parvizi, J. Diagnosis of periprosthetic joint infection: the threshold for serological markers. Clin Orthop Relat Res, 2013;471;3186-3195.
    Pubmed
  39. Johnson, AJ, Zywiel, MG, Stroh, A, Marker, DR, Mont, MA. Serological markers can lead to false negative diagnoses of periprosthetic infections following total knee arthroplasty. Int Orthop, 2011;35;1621-1626.
    Pubmed
  40. Parvizi, J, McKenzie, JC, Cashman, JP. Diagnosis of periprosthetic joint infection using synovial C-reactive protein. J Arthroplasty, 2012;27;12-16.
    Pubmed
  41. Tetreault, MW, Wetters, NG, Aggarwal, V, Mont, M, Parvizi, J, Della Valle, CJ. The Chitranjan Ranawat Award: should prophylactic antibiotics be withheld before revision surgery to obtain appropriate cultures?. Clin Orthop Relat Res, 30 Apr 2013[Epub]. http://dx.doi.org/10.1007/s11999-013-3016-5
  42. Aggarwal, VK, Higuera, C, Deirmengian, G, Parvizi, J, Austin, MS. Swab cultures are not as effective as tissue cultures for diagnosis of periprosthetic joint infection. Clin Orthop Relat Res, 2013;471;3196-3203.
    Pubmed
  43. Font-Vizcarra, L, Garcia, S, Mart?nez-Pastor, JC, Sierra, JM, Soriano, A. Blood culture flasks for culturing synovial fluid in prosthetic joint infections. Clin Orthop Relat Res, 2010;468;2238-2243.
    Pubmed
  44. Tsaras, G, Maduka-Ezeh, A, Inwards, CY, Mabry, T, Erwin, PJ, Murad, MH, Montori, VM, West, CP, Osmon, DR, Berbari, EF. Utility of intraoperative frozen section histopathology in the diagnosis of periprosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am, 2012;94;1700-1711.
    Pubmed
  45. Gomez, E, Cazanave, C, Cunningham, SA, Greenwood-Quaintance, KE, Steckelberg, JM, Uhl, JR, Hanssen, AD, Karau, MJ, Schmidt, SM, Osmon, DR, Berbari, EF, Mandrekar, J, Patel, R. Prosthetic joint infection diagnosis using broad-range PCR of biofilms dislodged from knee and hip arthroplasty surfaces using sonication. J Clin Microbiol, 2012;50;3501-3508.
    Pubmed
  46. Higuera C, Parvizi J. Culture negative PJI periprosthetic joint infection: strategies to improve yield [Internet]. Thorofare, NJ: Healio; [cited 2013 Aug 10]. , Available from: http://www.healio.com/orthopedics/hip/news/print/orthopedics-today/%7B92241423-c80c-4320-bb54-76a3f8e96978%7D/culture-negative-pji-periprosthetic-joint-infection-strategies-toimprove-yield
  47. Parvizi, J, Ghanem, E, Menashe, S, Barrack, RL, Bauer, TW. Periprosthetic infection: what are the diagnostic challenges?. J Bone Joint Surg Am, 2006;88;138-147.
    Pubmed
  48. Schafer, P, Fink, B, Sandow, D, Margull, A, Berger, I, Frommelt, L. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis, 2008;47;1403-1409.
    Pubmed
  49. Romano, CL, Manzi, G, Logoluso, N, Romano, D. Value of debridement and irrigation for the treatment of peri-prosthetic infections: a systematic review. Hip Int, 2012;22;S19-S24.
    Pubmed
  50. Sukeik, M, Patel, S, Haddad, FS. Aggressive early debridement for treatment of acutely infected cemented total hip arthroplasty. Clin Orthop Relat Res, 2012;470;3164-3170.
    Pubmed
  51. Odum, SM, Fehring, TK, Lombardi, AV, Zmistowski, BM, Brown, NM, Luna, JT, Fehring, KA, Hansen, EN, Periprosthetic Infection Consortium. Irrigation and debridement for periprosthetic infections: does the organism matter?. J Arthroplasty, 2011;26;114-118.
    Pubmed
  52. Hartman, MB, Fehring, TK, Jordan, L, Norton, HJ. Periprosthetic knee sepsis. The role of irrigation and debridement. Clin Orthop Relat Res, 1991;;113-118.
    Pubmed
  53. Marculescu, CE, Berbari, EF, Hanssen, AD, Steckelberg, JM, Harmsen, SW, Mandrekar, JN, Osmon, DR. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis, 2006;42;471-478.
    Pubmed
  54. Silva, M, Tharani, R, Schmalzried, TP. Results of direct exchange or debridement of the infected total knee arthroplasty. Clin Orthop Relat Res, 2002;;125-131.
    Pubmed
  55. Koyonos, L, Zmistowski, B, Della Valle, CJ, Parvizi, J. Infection control rate of irrigation and d?bridement for periprosthetic joint infection. Clin Orthop Relat Res, 2011;469;3043-3048.
    Pubmed
  56. Lora-Tamayo, J, Murillo, O, Iribarren, JA, Soriano, A, Sanchez-Somolinos, M, Baraia-Etxaburu, JM, Rico, A, Palomino, J, Rodriguez-Pardo, D, Horcajada, JP, Benito, N, Bahamonde, A, Granados, A, del Toro, MD, Cobo, J, Riera, M, Ramos, A, Jover-Saenz, A, Ariza, J, REIPI Group for the Study of Prosthetic Infection. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis, 2013;56;182-194.
    Pubmed
  57. Tsukayama, DT, Estrada, R, Gustilo, RB. Infection after total hip arthroplasty: a study of the treatment of one hundred and six infections. J Bone Joint Surg Am, 1996;78;512-523.
    Pubmed
  58. Zimmerli, W, Widmer, AF, Blatter, M, Frei, R, Ochsner, PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial: Foreign-Body Infection (FBI) Study Group. JAMA, 1998;279;1537-1541.
    Pubmed
  59. Azzam, KA, Seeley, M, Ghanem, E, Austin, MS, Purtill, JJ, Parvizi, J. Irrigation and debridement in the management of prosthetic joint infection: traditional indications revisited. J Arthroplasty, 2010;25;1022-1027.
    Pubmed
  60. Deirmengian, C, Greenbaum, J, Lotke, PA, Booth, RE, Lonner, JH. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. J Arthroplasty, 2003;18;22-26.
    Pubmed
  61. Munoz-Mahamud, E, Garcia, S, Bori, G, Martinez-Pastor, JC, Zumbado, JA, Riba, J, Mensa, J, Soriano, A. Comparison of a low-pressure and a high-pressure pulsatile lavage during debridement for orthopaedic implant infection. Arch Orthop Trauma Surg, 2011;131;1233-1238.
    Pubmed
  62. Schwechter, EM, Folk, D, Varshney, AK, Fries, BC, Kim, SJ, Hirsh, DM. Optimal irrigation and debridement of infected joint implants: an in vitro methicillin-resistant Staphylococcus aureus biofilm model. J Arthroplasty, 2011;26;109-113.
    Pubmed
  63. Buechel, FF, Femino, FP, D'Alessio, J. Primary exchange revision arthroplasty for infected total knee replacement: a long-term study. Am J Orthop (Belle Mead NJ), 2004;33;190-198.
    Pubmed
  64. Oussedik, SI, Dodd, MB, Haddad, FS. Outcomes of revision total hip replacement for infection after grading according to a standard protocol. J Bone Joint Surg Br, 2010;92;1222-1226.
    Pubmed
  65. Singer, J, Merz, A, Frommelt, L, Fink, B. High rate of infection control with one-stage revision of septic knee prostheses excluding MRSA and MRSE. Clin Orthop Relat Res, 2012;470;1461-1471.
    Pubmed
  66. von Foerster, G, Kluber, D, Kabler, U. Mid- to long-term results after treatment of 118 cases of periprosthetic infections after knee joint replacement using one-stage exchange surgery. Orthopade, 1991;20;244-252.
    Pubmed
  67. Goksan, SB, Freeman, MA. One-stage reimplantation for infected total knee arthroplasty. J Bone Joint Surg Br, 1992;74;78-82.
    Pubmed
  68. Lu, H, Kou, B, Lin, J. One-stage reimplantation for the salvage of total knee arthroplasty complicated by infection. Zhonghua Wai Ke Za Zhi, 1997;35;456-458.
    Pubmed
  69. Sofer, D, Regenbrecht, B, Pfeil, J. Early results of one-stage septic revision arthroplasties with antibiotic-laden cement. A clinical and statistical analysis. Orthopade, 2005;34;592-602.
    Pubmed
  70. Jackson, WO, Schmalzried, TP. Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res, 2000;;101-105.
    Pubmed
  71. Klouche, S, Leonard, P, Zeller, V, Lhotellier, L, Graff, W, Leclerc, P, Mamoudy, P, Sariali, E. Infected total hip arthroplasty revision: one- or two-stage procedure?. Orthop Traumatol Surg Res, 2012;98;144-150.
    Pubmed
  72. Parvizi, J, Adeli, B, Zmistowski, B, Restrepo, C, Greenwald, AS. Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection. J Bone Joint Surg Am, 2012;94;e104.
    Pubmed
  73. Freeman, MG, Fehring, TK, Odum, SM, Fehring, K, Griffin, WL, Mason, JB. Functional advantage of articulating versus static spacers in 2-stage revision for total knee arthroplasty infection. J Arthroplasty, 2007;22;1116-1121.
    Pubmed
  74. Meek, RM, Masri, BA, Dunlop, D, Garbuz, DS, Greidanus, NV, McGraw, R, Duncan, CP. Patient satisfaction and functional status after treatment of infection at the site of a total knee arthroplasty with use of the PROSTALAC articulating spacer. J Bone Joint Surg Am, 2003;85;1888-1892.
    Pubmed
  75. Romano, CL, Gala, L, Logoluso, N, Romano, D, Drago, L. Two-stage revision of septic knee prosthesis with articulating knee spacers yields better infection eradication rate than one-stage or two-stage revision with static spacers. Knee Surg Sports Traumatol Arthrosc, 2012;20;2445-2453.
    Pubmed
  76. Parvizi, J, Zmistowski, B, Adeli, B. Periprosthetic joint infection: treatment options. Orthopedics, 2010;33;659.
    Pubmed
  77. Kilgus, DJ, Howe, DJ, Strang, A. Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop Relat Res, 2002;;116-124.
    Pubmed
  78. Salgado, CD, Dash, S, Cantey, JR, Marculescu, CE. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res, 2007;461;48-53.
    Pubmed
  79. Parvizi, J, Azzam, K, Ghanem, E, Austin, MS, Rothman, RH. Periprosthetic infection due to resistant staphylococci: serious problems on the horizon. Clin Orthop Relat Res, 2009;467;1732-1739.
    Pubmed
  80. Walls, RJ, Roche, SJ, O'Rourke, A, McCabe, JP. Surgical site infection with methicillin-resistant Staphylococcus aureus after primary total hip replacement. J Bone Joint Surg Br, 2008;90;292-298.
    Pubmed
  81. Hanssen, AD, Spangehl, MJ. Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res, 2004;;79-85.
    Pubmed
  82. Glassman AH, Lachiewicz PF, Tanzer M. Orthopaedic knowledge update: hip and knee reconstruction 4. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2011. p. 202-207.
  83. Goldman, RT, Scuderi, GR, Insall, JN. 2-stage reimplantation for infected total knee replacement. Clin Orthop Relat Res, 1996;;118-124.
    Pubmed
  84. Haleem, AA, Berry, DJ, Hanssen, AD. Mid-term to long-term followup of two-stage reimplantation for infected total knee arthroplasty. Clin Orthop Relat Res, 2004;;35-39.
    Pubmed
  85. Insall, JN, Thompson, FM, Brause, BD. Two-stage reimplantation for the salvage of infected total knee arthroplasty. J Bone Joint Surg Am, 1983;65;1087-1098.
    Pubmed
  86. Diaz-Ledezma, C, Higuera, CA, Parvizi, J. Success after treatment of periprosthetic joint infection: a Delphi-based international multidisciplinary consensus. Clin Orthop Relat Res, 2013;471;2374-2382.
    Pubmed
  87. Jamsen, E, Stogiannidis, I, Malmivaara, A, Pajamaki, J, Puolakka, T, Konttinen, YT. Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach. Acta Orthop, 2009;80;67-77.
    Pubmed
  88. Barrack, RL, Engh, G, Rorabeck, C, Sawhney, J, Woolfrey, M. Patient satisfaction and outcome after septic versus aseptic revision total knee arthroplasty. J Arthroplasty, 2000;15;990-993.
    Pubmed
  89. Chen, AF, Kinback, NC, Heyl, AE, McClain, EJ, Klatt, BA. Better function for fusions versus above-the-knee amputations for recurrent periprosthetic knee infection. Clin Orthop Relat Res, 2012;470;2737-2745.
    Pubmed
  90. Patil, N, Lee, K, Huddleston, JI, Harris, AH, Goodman, SB. Aseptic versus septic revision total knee arthroplasty: patient satisfaction, outcome and quality of life improvement. Knee, 2010;17;200-203.
    Pubmed


e-submission

This Article


Cited By Articles

Social Network Service

Archives

Indexed/Covered by